Personalized brain therapy hits 68 percent remission for PTSD
The Optimist Daily reports that an FDA-cleared personalized Magnetic e-Resonance Therapy (MeRT), developed by Wave Neuroscience with Texas A&M researchers, reportedly produced 68% remission in clinical trials for PTSD—far higher than commonly used medications. The result is presented as a promising clinical advance for treating PTSD, according to the article excerpt.
Why this is good news
The reported 68% remission rate suggests this FDA-cleared, personalized MeRT approach could offer greater symptom remission for people with PTSD than commonly used medications, indicating a potential benefit for patients seeking alternatives. The involvement of Wave Neuroscience and Texas A&M and the FDA clearance make further clinical evaluation and real-world access important next considerations, while the report itself does not establish long-term effectiveness.
What happens next
What were the trial methods, sample size and outcome measures, and can independent studies replicate the reported 68% remission for MeRT in PTSD?
.jpg){kind=link}